Is There Any Risk of Intracranial Hemorrhage Using Tipranavir?

Is There Any Risk of Intracranial Hemorrhage Using Tipranavir?

Ivana Maida

NULL

*Correspondence: Ivana Maida, Email not available

Abstract

Is There Any Risk of Intracranial Hemorrhage Using Tipranavir?

Ritonavir-boosted tipranavir is indicated for antiretroviraltreatment of adult patients infected with HIV-1 with evidence of viral replication and who aretreatment-experienced or have HIV-1 strains resistantto protease inhibitors.

Contents

DOI not available
    DOI not available